Lv5
1038 积分 2023-12-05 加入
Pharmacologic glycoengineering of Fcγ receptor IIIa enhances force-resistant IgG-FcγR interactions and anti-tumor antibody efficacy
4个月前
已完结
Site-Specific Antibody–Drug Conjugation through Glycoengineering
4个月前
已完结
Glycoengineering design options for IgG1 in CHO cells using precise gene editing
5个月前
已完结
Evaluation of Two Chemoenzymatic Glycan Remodeling Approaches to Generate Site-Specific Antibody–Drug Conjugates
5个月前
已完结
One-step synthesis of site-specific antibody–drug conjugates by reprograming IgG glycoengineering with LacNAc-based substrates
5个月前
已完结
Heterogeneous plasma cells and long-lived subsets in response to immunization, autoantigen and microbiota
5个月前
已完结
A HER2 target antibody drug conjugate combined with anti-PD-(L)1 treatment eliminates hHER2+ tumors in hPD-1 transgenic mouse model and contributes immune memory formation
6个月前
已完结
Development of bifunctional anti-PD-L1 antibody MMAE conjugate with cytotoxicity and immunostimulation
6个月前
已完结
Targeting the poliovirus receptor to activate T cells and induce myeloid-derived suppressor cells to differentiate to pro-inflammatory macrophages via the IFN-γ-p-STAT1-IRF8 axis in cancer therapy
6个月前
已完结
Targeting the immune privilege of tumor-initiating cells to enhance cancer immunotherapy
6个月前
已完结
皖公网安备34019202002308
